Independence Blue Cross has instituted an 18-month benefit exclusion on certain drugs that receive accelerated approval from ...
Eli Lilly’s obesity drug Zepbound is now covered by Medicare for sleep apnea treatment, expanding access to the costly ...
Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...
Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...
Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
Sanofi's phase 3 study shows Sarclisa SC matches IV formulation in efficacy for relapsed myeloma. Regulatory submissions are ...
GlobalData on MSN14h
Palforzia’s peanut allergy treatment use in Europe expanded to toddlersThe EC has approved the extension of Stallergenes Greer’s Palforzia for the treatment of peanut allergy in toddlers.
The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...
According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback